The ability of l-carnosine to protect against oxaliplatin-induced peripheral neuropathy has been partly attributed to the increased Nrf2 with its antioxidant machinery and the inhibition of both NF-κB and TNF-α (Yehia et al. 2019). The gene discussed is NFKB1; the disease is peripheral neuropathy.